Pregled bibliografske jedinice broj: 734376
Postprandijalna hiperglikemija kao cimbenik rizika u nastanku endotelne disfunkcije - mogucnost prevencije
Postprandijalna hiperglikemija kao cimbenik rizika u nastanku endotelne disfunkcije - mogucnost prevencije // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 130 (2008), 21-25 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 734376 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Postprandijalna hiperglikemija kao cimbenik rizika u nastanku endotelne disfunkcije - mogucnost prevencije
(Postprandial Hyperglycemia as a Risk Factor in the Development of Endothelial Dysfunction – how to prevent?)
Autori
Ljubic, Spomenka ; Boras, Jozo ; Vidjak, Vinko ;
Izvornik
Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora (0024-3477) 130
(2008);
21-25
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Hiperglikemija – komplikacije; patofiziologija; farmakoterapija; Postprandijalni period; Vaskularni endotel – patofiziologija; [e};erna bolest; komplikacije – patofiziologija; Oksidativni stres – fiziologija; Upala – patofiziologija
(Hyperglycemia – complications; physiopathology; drug therapy; Postprandial period; Endothelium; vascular – physiopathology; Diabetes complications – physiopathology; Oxidative stress – physiology; Inflammation – physiopathology)
Sažetak
Diabetes mellitus is characterised by insufficient insulin secretion and/or insufficient utilisation of glucose. It results in hyperglycemia which is the main reason for the development of late complications of diabetes mellitus. Postprandial hyperglycemia is important in the development of complications because it is accompanied with oxidative stress, inflammation and finally with endothelial dysfunction. Under investigation are superoxide dismutase, catalase, L-propionyl-carnitine, lipoic acid, LY 333351, PJ34, FP15 which is expected to be useful in oxidative stress and early prevention of complications. As opposed to these substances which are still under investigation, drugs like thiazolidinediones, statins and renin-angiotensin system inhibitors have proven, antioxidant effect, aside of their already known clinical indications. Today we have a lot of opportunities to reduce hyperglycemia but also oxidative stress, inflammation and disturbances of coagulation system, and so prevent in very early stages endothelial dysfunction and consequently the late complications of diabetes.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus
- MEDLINE